🔖
Bu Makaleye Atıf Yap
HOŞGELEN, E. I., ALPTEKİN, K. (2021). COVID-19 SALGINININ ŞİZOFRENİ HASTALARINDAKİ ETKİSİ. Türk Psikiyatri Dergisi, Cilt: 32 - Sayı: 3, 219–221. https://ajindex.com/articles/418546
Dergiler / Türk Psikiyatri Dergisi / 2021 / Cilt: 32 - Sayı: 3
COVID-19 SALGINININ ŞİZOFRENİ HASTALARINDAKİ ETKİSİ
- Sayfa
- 219–221
- DOI
- —
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗Kaynakça (6)
- Anadolu Ajansı (2020, Mart 11) Sağlık Bakanı Koca Türkiye’de ilk koronavirüs vakasının görüldüğünü açıkladı, 28 Mayıs 2020’de https://www.aa.com. tr/tr/koronavirus/saglik-bakani-koca-turkiyede-ilk-koronavirus-vakasiningoruldugunu-acikladi/1761466. adresinden indirildi. Brown E, Gray R, Lo Monaco S ve ark. (2020) The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. Schizophr Res 222: 79-87.
- Cohn T, Prud’homme D, Streiner D ve ark. (2004) Characterizing coronary heart disease risk in chronic schizophrenia: High prevalence of the metabolic syndrome. Can J Psychiatry 49:753–60.
- Cowan HR (2020) Is schizophrenia research relevant during the COVID-19 pandemic?. Schizophr Res 220:271–2.
- Çakıroğlu S, Ertaş E, Alyanak B (2020) Letter To The Editor - The Covid-19 Pandemic And Mental Health As Issues Considered Within The Context Of Adjustment Disorder And Psychosocial Interventions. Turk Psikiyatri Derg 31:148-50.
- Dinan T, Holt R, Kohen D ve ark. (2004) “Schizophrenia and diabetes 2003” expert consensus meeting, Dublin, 3-4 october 2003: Consensus summary. Br J Psychiatry 184 (Suppl. 47): 0–2.
- Krieger I, Bitan DT, Comaneshter D ve ark. (2019) Increased risk of smokingrelated illnesses in schizophrenia patients: A nationwide cohort study. Schizophr Res 212:121–5. Palomar-Ciria N, del Valle PB, Hernández-Las Heras MÁ ve ark. (2020) Schizophrenia and COVID-19 delirium. Psychiatry Res 290:113137. Yao H, Chen JH, Xu YF (2020) Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 7: e21. World Health Organization (2020, Mart 25). Covid-19: Vulnerable and High Risk Group, Geneva, Switzerland: World Health Organization, 28 Mayıs 2020’de https://www.who.int/westernpacific/emergencies/covid-19/ information/high-risk-groups adresinden indirildi.